Laust Bruun Johnsen

Title: Laust Bruun Johnsen: Innovator in Procoagulant Antibodies

Introduction

Laust Bruun Johnsen is a notable inventor based in Skodsborg, Denmark. He has made significant contributions to the field of biomedicine, particularly in the development of procoagulant antibodies. With a total of 6 patents, his work has the potential to impact the treatment of coagulopathies such as hemophilia A.

Latest Patents

Johnsen's latest patents focus on improved procoagulant antibodies. One of his inventions involves bispecific antibodies that can bind to coagulation Factor IX (FIX) and its activated form, Factor IXa (FIXa), as well as Factor X (FX) and its activated form, Factor Xa (FXa). These antibodies promote FX activation by FIXa and offer methods and compositions for treating individuals suffering from coagulopathy. Another patent details multispecific procoagulant antibodies that also target FIX and FX, enhancing the treatment options available for hemophilia A patients.

Career Highlights

Throughout his career, Laust Bruun Johnsen has worked with prominent organizations such as Novo Nordisk A/S and Sanquin Blood Supply Foundation. His experience in these companies has allowed him to refine his expertise in antibody development and therapeutic applications.

Collaborations

Johnsen has collaborated with notable colleagues, including Henriet Meems and Alexander Benjamin Meijer. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Laust Bruun Johnsen's innovative work in procoagulant antibodies showcases his commitment to improving treatments for coagulopathies. His contributions to the field are significant and continue to pave the way for advancements in biomedical research.